All > Sbrt

SGRT for Lung

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
LungSGRT - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing two different radiation therapy techniques for tumors in the lungs. One technique uses a guidance system to help target the radiation, and the other doesn't.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Papaverine Hydrochloride
1
Radiation Therapy
1
GC4711

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 months

12 months
Incidence of SBRT and fiducial-related pulmonary toxicities as assessed by NCI CTCAE v.5.0

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Papaverine Hydrochloride
1
Radiation Therapy
1
GC4711

Trial Design

3 Treatment Groups

Group 2
1 of 3
Group 3
1 of 3
Group 1
1 of 3

Experimental Treatment

45 Total Participants · 3 Treatment Groups

Primary Treatment: SGRT · No Placebo Group · N/A

Group 2
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device
Group 3
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device
Group 1
Device
Experimental Group · 1 Intervention: SGRT · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,122 Previous Clinical Trials
1,126,997 Total Patients Enrolled
2 Trials studying Lung
131 Patients Enrolled for Lung
Atrium HealthLead Sponsor
121 Previous Clinical Trials
35,381 Total Patients Enrolled
1 Trials studying Lung
61 Patients Enrolled for Lung
John Heinzerling, MDPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to understand and comply with study procedures for the entire length of the study.
Women of child-bearing potential and non-sterilized men who are sexually active with a woman of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study treatment
You are eligible for release of your personal health information.\n
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top